Rational design and biological validation of EZH2/PD-L1 bifunctional inhibitors for colorectal cancer immunotherapy
ObjectivesThis study aims to identify novel small-molecule inhibitors that target both PD-L1 and EZH2 to enhance colorectal cancer immunotherapy.MethodsA combination of computer-aided molecular simulation, homogeneous time-resolved fluorescence (HTRF) …